2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) is an environmental contami
nant that produces adverse biological effects including developmental
toxicity and teratogenesis. In the mouse embryo, TCDD induces cleft pa
late and hydronephrosis. The synthetic glucocorticoid, hydrocortisone
(HC), induces cleft palate and a potent, synergistic interaction has b
een observed between TCDD and HC in C57BL/6N embryonic mice. The morph
ology and etiology of TCDD- and HC-induced clefts are distinctly diffe
rent with formation of small palatal shelves following HC exposure and
failure of normally-sized shelves to fuse after TCDD treatment. Each
exposure also alters expression of several growth factors. When EGF, T
GFG alpha, EGF receptor, and the TGF beta's are considered as a combin
atorial, interacting set of regulators, TCDD and HC each produce a uni
que pattern of increased and/or decreased expression across the set. T
he interaction of HC and TCDD results in a cleft palate whose etiology
most closely resembles that observed after HC exposure, i.e. small pa
latal shelves. HC + TCDD-exposure also produces a pattern of growth fa
ctor expression which closely resembles that seen after HC. Both TCDD
and HC act through receptor-mediated mechanisms and each compound has
its own receptor. The Ah receptor (AhR) binds TCDD and the glucocortic
oid receptor (GR) binds HC. On gestation day (GD) 14, in the embryonic
palate exposed to TCDD, the AhR was downregulated and the GR expressi
on increased. Conversely, following HC exposure, the GR was downregula
ted and AhR levels were elevated. HC + TCDD produced increased express
ion of both receptors and this pattern would be predicted to produce H
C-like clefts as the GR-mediated responses would result in small palat
al shelves. The observed cross-regulation of the receptors is believed
to be important in the synergistic interaction between TCDD and HC fo
r the induction of cleft palate.